[1]LACKNER C, KNISELY AS.Liver biopsy in children and adolescents:Preliminary morphological examinations in diffuse liver disease[J].Pathologe, 2017, 26 (6) :1316-1324.
|
[2]POORTEN VD, KORK A, LAM T, et al.Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital[J].Intern Med J, 2010, 36 (11) :692-699.
|
[3]PICCININO F, SAGNELLI E, PASQUALE G, et al.Complications following percutaneous liver biopsy.A multicentre retrospective study on 68, 276 biopsies[J].J Hepatol, 1986, 2 (2) :165-173.
|
[4]KOCAB M, NORD H, BRANTLEY S, et al.Prospective randomized single-blinded evaluation of adequacy of percutaneous liver biopsy by standard Menghini-type (SM) and spring-loaded-type (SL) needles[J].Gastroenterology, 1998, 114 (4) :A1277.
|
[5]STOECKHERT E.Liver biopsy:Is it still relevant?[J].Intern Med J, 2010, 36 (11) :689-691.
|
[6]EMANUELE E.Is biopsy always necessary?Toward a clinico-laboratory approach for diagnosing nonalcoholic steatohepatitis in obesity[J].Hepatology, 2010, 48 (6) :2086-2087.
|
[7]HUANG FC.Ultrasound diagnosis for 198 psychiatric patients with fatty liver and result analysis[J].Med J Chin People’s Health, 2014, 26 (24) :25-26. (in Chinese) 黄福春.超声诊断精神科脂肪肝患者198例结果分析[J].中国民康医学, 2014, 26 (24) :25-26.
|
[8]LIANG W, TANG HL, QUAN XY, et al.Preliminary application of 64-slice spiral CT whole-liver perfusion in hepatocellular carcinoma[J].Chin J Med Imaging Technol, 2007, 23 (5) :707-710. (in Chinese) 梁文, 唐海亮, 全显跃, 等.64层螺旋CT全肝灌注模式成像在肝细胞癌中的初步应用[J].中国医学影像技术, 2007, 23 (5) :707-710.
|
[9]RONOT M, AHSSEL TV, MICHOUX N, et al.Liver fibrosis in chronic hepatitis C virus infection:Differentiating minimal from intermediate fibrosis with perfusion CT[J].Radiology, 2010, 256 (1) :135-142.
|
[10]LONG LL, HUANG ZK, DING K, et al.Application value multi-slice spiral CT liver perfusion imaging in the chronic hepatic fibrosis and cirrhosis[J].Chin J Radiol, 2012, 46 (4) :317-321. (in Chinese) 龙莉玲, 黄仲奎, 丁可, 等.多层螺旋CT肝脏灌注成像评价慢性肝纤维化、肝硬化的价值[J].中华放射学杂志, 2012, 46 (4) :317-321.
|
[11]NIU M, DENG DY, LI YPF, et al.Values of MRE in diagnosis of stages of hepatic fibrosis:A Meta-analysis[J].J Jilin Univ:Med Edit, 2017, 43 (4) :787-793. (in Chinese) 牛猛, 邓大勇, 李云鹏飞, 等.磁共振弹性成像对肝纤维化分级诊断分值的Meta分析[J].吉林大学学报:医学版, 2017, 43 (4) :787-793.
|
[12]PETITCLERC L, SEBASTIANI G, GILBERT G, et al.Liver fibrosis:Review of current imaging and MRI quantification techniques[J].JMRI, 2017, 45 (5) :1276.
|
[13]LI ZB, SHAO Q, ZHANG J, et al.Study on the influence of alanine transaminase to the accuracy of hepatic hardness diagnosed by FibroScan[J].Prog Mod Biomed, 2012, 12 (36) :7040-7043. (in Chinese) 李忠斌, 邵清, 张健, 等.丙氨酸转氨酶对FibroScan诊断肝硬度准确性的影响[J].现代生物医学进展, 2012, 12 (36) :7040-7043.
|
[14]KLADNEY RD, BULLA GA, GUO L, et al.GP73, a novel Golgi-localized protein upregulated by viral infection[J].Gene, 2000, 249 (1) :53-65.
|
[15]WRIGHT LM, YONG S, PICKEN MM, et al.Decreased survival and hepato-renal pathology in mice with C-terminally truncated GP73 (GOLPH2) [J].Int J Clin Exp Pathol, 2009, 2 (1) :34-47.
|
[16]KLADENY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.
|
[17]BACHERT C, FIMMEL C, LINSTEDT AD.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma[J].Traffic, 2010, 8 (10) :1415-1423.
|
[18] KLADNEY RD, CUI X, BULLA GA, et al.Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease[J].Hepatology, 2002, 35 (6) :1431-1440.
|
[19]WEI HS, KANG YF, HAO XH, et al.Serum GP73 were increased in patients with fatty liver disease[J].Chin J Exp Clin Virol, 2013, 27 (4) :244-246. (in Chinese) 魏红山, 康艳芳, 郝晓花, 等.肝细胞脂肪变对血清糖蛋白GP73水平的影响[J].中华实验和临床病毒学杂志, 2013, 27 (4) :244-246.
|
[20]IFTIKHAR R, KLADNEY RD, HAVLIOGLU N, et al.Diseaseand cell-specific expression of GP73 in human liver disease[J].Am J Gastroenterol, 2004, 99 (6) :1087.
|
[21]MAO Y, YANG H, XU H, et al.Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma[J].Gut, 2010, 59 (12) :1687-1693.
|
[22]CAO Z, LI Z, WANG H, et al.Algorithm of Golgi protein 73and liver stiffness accurately diagnoses significant fibrosis in chronic HBV infection[J].Liver Int, 2017, 37 (11) :1612.
|
[23]FARCI P, WOLLENBERG K, DIAZ G, et al.Profibrogenic chemokines and viral evolution predict rapid progression of hepatitis C to cirrhosis[J].Proc Natl Acad Sci U S A, 2012, 109 (36) :14562-14567.
|
[24] LUO KX, CHEN JJ, LI P.Hepatitis B basic biology and clinical science[M].Beijing:People’s Medical Publishing House, 1997:397. (in Chinese) 洛抗先, 陈金军, 李平.乙型肝炎基础与临床[M].北京:人民卫生出版社, 1997:397.
|
[25]XU ZJ, PAN XN, WEI KP, et al.Serum Golgi protein 73 levels and liver pathological grading in cases of chronic hepatitis B[J].Mol Med Rep, 2015, 11 (4) :2644-2652.
|
[26]XU Z, LIU L, PAN X, et al.Serum Golgi proetopancreatobiliaatein 73 (GP73) is a diagnostic and prognostic marker of chronic HBV liver disease[J].Medicine, 2015, 94 (12) :e659.
|
[27]YAO MJ, WANG LJ, GUAN GW, et al.Value of serum Golgi protein 73 in assisting the diagnosis of moderate or severe liver injury in patients with chronic hepatitis B[J].J Clin Hepatol, 2018, 34 (4) :755-759. (in Chinese) 姚明解, 王雷婕, 关贵文, 等.血清高尔基体蛋白73在辅助诊断慢性乙型肝炎患者中度以上肝损伤中的应用[J].临床肝胆病杂志, 2018, 34 (4) :755-759.
|
[28]WEI H, LI B, ZHANG R, et al.Serum GP73, a marker for evaluating progression in patients with chronic HBV infections[J].PLo S One, 2013, 8 (2) :e53862.
|
[29]WEISKIRCHEN R, TACKE F.Combining GP73 with liver stiffness measurements:A proof-of-concept for non-invasive fibrosis assessment in antiviral-na6ve HBV patients[J].Liver Int, 2017, 37 (11) :1605.
|
[30]QIAO Y, CHEN J, LI X, et al.Serum GP73 is also a biomarker for diagnosing cirrhosis in population with chronic HBV infection[J].Clin Biochem, 2014, 47 (16-17) :216-222.
|